Trial Profile
Safety and efficacy of combination of gemcitabine and cisplatin with or without Endostar in patients with advanced thymoma and thymic carcinoma
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Nov 2017
Price :
$35
*
At a glance
- Drugs Cisplatin (Primary) ; Endostatin (Primary) ; Gemcitabine (Primary)
- Indications Malignant thymoma; Thymoma
- Focus Therapeutic Use
- 08 Nov 2017 New trial record
- 18 Oct 2017 Results presented at the 18th World Conference on Lung Cancer